InsidersTradesSigma
Explore the detailed record of transactions filed by Colleran David, Directeur Exécutif, Conseiller Juridique Général. Director active across 1 companies, notably Anika Therapeutics, Inc.. Aggregated, 4 filings have been recorded. Total volume traded: €67k. The latest transaction was filed on 11 May 2022 (Acquisition). Regulator: SEC (Form 4). All data is openly available.
4 of 4 declarations
David Colleran is the EVP, General Counsel, and Corporate Secretary at Anika Therapeutics, Inc. He oversees the company's legal and regulatory affairs and ensures compliance with applicable laws. Colleran plays a key role in risk management and protecting the company's interests.